Baker Bros. Advisors’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $7.87M | Sell |
|
|||||
|
2018
Q1 | $17.2M | Sell |
|
|||||
|
2017
Q4 | $18.7M | Hold |
|
|||||
|
2017
Q3 | $23.2M | Hold |
|
|||||
|
2017
Q2 | $21.4M | Hold |
|
|||||
|
2017
Q1 | $29.7M | Hold |
|
|||||
|
2016
Q4 | $27.2M | Sell |
|
|||||
|
2016
Q3 | $23.1M | Sell |
|
|||||
|
2016
Q2 | $16.8M | Sell |
|
|||||
|
2016
Q1 | $19M | Hold |
|
|||||
|
2015
Q4 | $26.7M | Hold |
|
|||||
|
2015
Q3 | $24.9M | Hold |
|
|||||
|
2015
Q2 | $32.5M | Hold |
|
|||||
|
2015
Q1 | $26M | Sell |
|
|||||
|
2014
Q4 | $33.6M | Hold |
|
|||||
|
2014
Q3 | $23.1M | Hold |
|
|||||
|
2014
Q2 | $19.2M | Hold |
|
|||||
|
2014
Q1 | $18.2M | Buy |
|
|||||
|
2013
Q4 | $22.4M | Hold |
|
|||||
|
2013
Q3 | $21.1M | Hold |
|
|||||
|
2013
Q2 | $18.7M | Buy |
|